Starting October 17, 2026, Indonesia will enforce mandatory halal certification for a wide range of imports. This change requires Indian exporters of food, pharmaceuticals, and cosmetics to undergo strict pre-shipment audits. The regulation may increase operational costs and cause supply chain bottlenecks for companies doing business with the country.
Indian exporters are bracing for a significant regulatory shift as Indonesia prepares to implement its expanded mandatory halal certification regime, known as 'Wajib Halal Oktober 2026' (WHO 2026). Effective October 17, 2026, this policy mandates that a broad array of imported goods—ranging from processed foods and agricultural products to pharmaceuticals and cosmetics—must carry certified halal documentation to enter the Indonesian market.
New Compliance Standards for Indian Goods
The move marks a departure from previous norms, removing the option for self-declaration of compliance. Under the new BPJPH Regulation No. 4/2026, foreign products must now undergo a pre-shipment conformity assessment. This means companies cannot simply ship goods and hope for clearance at the border; they must ensure that their entire supply chain, including raw materials and manufacturing additives, is traceable and audited by inspection bodies recognized by Indonesia’s Halal Product Assurance Organizing Agency (BPJPH).
Manufacturers are now required to register their products through the SIHALAL portal. For sectors like pharmaceuticals, this is particularly complex, as it involves scrutiny of gelatin capsules and alcohol-based formulations, which are common in many medicines. The requirement covers not just the final product but the processes used in production, storage, and transport, introducing a new layer of technical compliance for Indian exporters.
Financial and Operational Risks
This regulatory update comes at a time when bilateral trade between India and Indonesia has been facing headwinds. Total trade between the two nations reached approximately $24.8 billion in the 2025-26 fiscal year, a significant decline from the $38.8 billion recorded in 2022-23. The additional costs associated with these audits could further pressure profit margins for Indian exporters, particularly those in the SME sector that may struggle to absorb the expense of international certification and inspection.
There is also a material risk of logistical disruptions. If documentation is incomplete or audit results do not match the shipments arriving at Indonesian ports, companies face the risk of customs rejection, border seizures, or forced product recalls. This could lead to revenue losses and inventory write-offs for companies that fail to synchronize their supply chains with the new Indonesian requirements before the deadline.
Next Steps for Investors
Investors and market participants should monitor how quickly Indian exporters can adapt to these documentation requirements. The primary monitorable will be the impact on export volumes for sectors like agricultural commodities, pharmaceuticals, and consumer goods. While larger firms with established international quality systems may adapt more quickly, smaller players or those with complex multi-ingredient supply chains may face a period of volatility in their Indonesian trade operations. Market sentiment regarding these exporters will likely depend on their ability to minimize disruptions and maintain uninterrupted trade flows once the October deadline passes.